RUBY
Rubius Therapeutics Inc
Price:  
0.08 
USD
Volume:  
18,983,900.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RUBY Relative Valuation

-104179.0%
Upside

As of 2025-07-07, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (86.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -104179.0%.

The range of the Relative Valuation is (72.64) - (85.55) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.4x - 29.6x 27.0x
Forward P/E multiples 25.1x - 41.6x 32.7x
Fair Price (72.64) - (85.55) (86.39)
Upside -87617.0% - -103167.9% -104179.0%
0.08 USD
Stock Price
(86.39) USD
Fair Price

RUBY Relative Valuation - Historical P/E Data

Date P/E